Name: Laura Boros
New title: President of Pharmaceutical Systems, Becton Dickinson
Previous title: Senior Vice President of Global Nutrition, Reckitt
Becton Dickinson has filled the gap at the top of its pharmaceutical systems division, hiring Laura Boros to occupy the vacancy created by the promotion of Eric Borin late last year.
The pharmaceutical systems division at BD makes a range of glass prefillable syringes such as Hypak, Effivax and Hylok. Pharmaceutical systems is a small but fast-growing part of the business. At $292 million, U.S. sales over the first six months of BD’s financial year were lower than any other division but its growth, 28.2%, was the fastest at the company.
Responsibility for maintaining the growth, which is fueled by rising demand for biologics and vaccines, will fall on Boros, who has spent the past decade working in the nutrition and over-the-counter medicine markets. Boros spent the past three years at Reckitt, where she worked as SVP of global nutrition, and previously held positions at GSK and Novartis.
At BD, Boros will report to Mike Garrison, president of the medical segment that houses the pharmaceutical systems division.
“Her global experience, coupled with her track record of driving innovation across the healthcare and consumer industries, will support the next generation of PS growth as it continues to enhance the delivery of medications for the pharmaceutical industry and patients around the world,” Garrison said in a statement.
Boros’ appointment fills a vacancy created when BD promoted Borin to lead the larger medication delivery solutions division late last year. Globally, medication delivery solutions generated more than twice the sales of pharmaceutical systems over the first half of the financial year, but its revenues declined year-over-year.
